157 related articles for article (PubMed ID: 30085149)
1. Enantiospecific pharmacokinetics and drug-drug interactions of primaquine and blood-stage antimalarial drugs.
Chairat K; Jittamala P; Hanboonkunupakarn B; Pukrittayakamee S; Hanpithakpong W; Blessborn D; White NJ; Day NPJ; Tarning J
J Antimicrob Chemother; 2018 Nov; 73(11):3102-3113. PubMed ID: 30085149
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic interactions between primaquine and pyronaridine-artesunate in healthy adult Thai subjects.
Jittamala P; Pukrittayakamee S; Ashley EA; Nosten F; Hanboonkunupakarn B; Lee SJ; Thana P; Chairat K; Blessborn D; Panapipat S; White NJ; Day NP; Tarning J
Antimicrob Agents Chemother; 2015 Jan; 59(1):505-13. PubMed ID: 25385096
[TBL] [Abstract][Full Text] [Related]
3. Open-label crossover study of primaquine and dihydroartemisinin-piperaquine pharmacokinetics in healthy adult thai subjects.
Hanboonkunupakarn B; Ashley EA; Jittamala P; Tarning J; Pukrittayakamee S; Hanpithakpong W; Chotsiri P; Wattanakul T; Panapipat S; Lee SJ; Day NP; White NJ
Antimicrob Agents Chemother; 2014 Dec; 58(12):7340-6. PubMed ID: 25267661
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers.
Chotsiri P; Wattanakul T; Hoglund RM; Hanboonkunupakarn B; Pukrittayakamee S; Blessborn D; Jittamala P; White NJ; Day NPJ; Tarning J
Br J Clin Pharmacol; 2017 Dec; 83(12):2752-2766. PubMed ID: 28695570
[TBL] [Abstract][Full Text] [Related]
5. Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers.
von Seidlein L; Hanboonkunupakarn B; Jittamala P; Pongsuwan P; Chotivanich K; Tarning J; Hoglund RM; Winterberg M; Mukaka M; Peerawaranun P; Sirithiranont P; Doran Z; Ockenhouse CF; Ivinson K; Lee C; Birkett AJ; Kaslow DC; Singhasivanon P; Day NPJ; Dondorp AM; White NJ; Pukrittayakamee S
Hum Vaccin Immunother; 2020; 16(1):33-41. PubMed ID: 31306084
[No Abstract] [Full Text] [Related]
6. Safety, Pharmacokinetics, and Mosquito-Lethal Effects of Ivermectin in Combination With Dihydroartemisinin-Piperaquine and Primaquine in Healthy Adult Thai Subjects.
Kobylinski KC; Jittamala P; Hanboonkunupakarn B; Pukrittayakamee S; Pantuwatana K; Phasomkusolsil S; Davidson SA; Winterberg M; Hoglund RM; Mukaka M; van der Pluijm RW; Dondorp A; Day NPJ; White NJ; Tarning J
Clin Pharmacol Ther; 2020 May; 107(5):1221-1230. PubMed ID: 31697848
[TBL] [Abstract][Full Text] [Related]
7. Mass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination.
Gerardin J; Eckhoff P; Wenger EA
BMC Infect Dis; 2015 Mar; 15():144. PubMed ID: 25887935
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic interactions between primaquine and chloroquine.
Pukrittayakamee S; Tarning J; Jittamala P; Charunwatthana P; Lawpoolsri S; Lee SJ; Hanpithakpong W; Hanboonkunupakarn B; Day NP; Ashley EA; White NJ
Antimicrob Agents Chemother; 2014 Jun; 58(6):3354-9. PubMed ID: 24687509
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic Interactions between Tafenoquine and Dihydroartemisinin-Piperaquine or Artemether-Lumefantrine in Healthy Adult Subjects.
Green JA; Mohamed K; Goyal N; Bouhired S; Hussaini A; Jones SW; Koh GC; Kostov I; Taylor M; Wolstenholm A; Duparc S
Antimicrob Agents Chemother; 2016 Dec; 60(12):7321-7332. PubMed ID: 27697758
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of piperaquine after repeated oral administration of the antimalarial combination CV8 in 12 healthy male subjects.
Röshammar D; Hai TN; Friberg Hietala S; Van Huong N; Ashton M
Eur J Clin Pharmacol; 2006 May; 62(5):335-41. PubMed ID: 16570188
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of chloroquine and primaquine in healthy volunteers.
Daher A; Pinto DP; da Fonseca LB; Pereira HM; da Silva DMD; da Silva LSFV; Esteves AL; Soares Medeiros JJ; Mendonça JS
Malar J; 2022 Jan; 21(1):16. PubMed ID: 34998391
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of (+)-primaquine and (-)-primaquine enantiomers in rhesus macaques (Macaca mulatta).
Saunders D; Vanachayangkul P; Imerbsin R; Khemawoot P; Siripokasupkul R; Tekwani BL; Sampath A; Nanayakkara NP; Ohrt C; Lanteri C; Gettyacamin M; Teja-Isavadharm P; Walker L
Antimicrob Agents Chemother; 2014 Dec; 58(12):7283-91. PubMed ID: 25267666
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic Modeling of Primaquine Pharmacokinetics, Gametocytocidal Activity, and Mosquito Infectivity.
Chotsiri P; Mahamar A; Hoglund RM; Koita F; Sanogo K; Diawara H; Dicko A; Simpson JA; Bousema T; White NJ; Brown JM; Gosling R; Chen I; Tarning J
Clin Pharmacol Ther; 2022 Mar; 111(3):676-685. PubMed ID: 34905220
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine.
Daher A; Aljayyoussi G; Pereira D; Lacerda MVG; Alexandre MAA; Nascimento CT; Alves JC; da Fonseca LB; da Silva DMD; Pinto DP; Rodrigues DF; Silvino ACR; de Sousa TN; de Brito CFA; Ter Kuile FO; Lalloo DG
Malar J; 2019 Sep; 18(1):325. PubMed ID: 31547827
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy of artesunate in Plasmodium vivax malaria in Thailand.
Hamedi Y; Safa O; Zare S; Tan-ariya P; Kojima S; Looareesuwan S
Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):570-4. PubMed ID: 15689068
[TBL] [Abstract][Full Text] [Related]
16. Determinants of Primaquine and Carboxyprimaquine Exposures in Children and Adults with Plasmodium vivax Malaria.
Chu CS; Watson JA; Phyo AP; Win HH; Yotyingaphiram W; Thinraow S; Soe NL; Aung AA; Wilaisrisak P; Kraft K; Imwong M; Hanpithakpong W; Blessborn D; Tarning J; Proux S; Ling C; Nosten FH; White NJ
Antimicrob Agents Chemother; 2021 Oct; 65(11):e0130221. PubMed ID: 34398667
[TBL] [Abstract][Full Text] [Related]
17. Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria.
Sinclair D; Gogtay N; Brand F; Olliaro P
Cochrane Database Syst Rev; 2011 Jul; (7):CD008492. PubMed ID: 21735431
[TBL] [Abstract][Full Text] [Related]
18. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
[TBL] [Abstract][Full Text] [Related]
19. Clinical trial of oral artesunate with or without high-dose primaquine for the treatment of vivax malaria in Thailand.
Silachamroon U; Krudsood S; Treeprasertsuk S; Wilairatana P; Chalearmrult K; Mint HY; Maneekan P; White NJ; Gourdeuk VR; Brittenham GM; Looareesuwan S
Am J Trop Med Hyg; 2003 Jul; 69(1):14-8. PubMed ID: 12932090
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and
Anh CX; Chavchich M; Birrell GW; Van Breda K; Travers T; Rowcliffe K; Lord AR; Shanks GD; Edstein MD
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31907186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
